Literature DB >> 15616343

First isolation of bla(VIM-2) in Klebsiella oxytoca clinical isolates from Portugal.

T Conceição, A Brízio, A Duarte, R Barros.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15616343      PMCID： PMC538894          DOI： 10.1128/AAC.49.1.476.2005

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


× No keyword cloud information.
  10 in total

Review 1.  Emerging carbapenemases in Gram-negative aerobes.

Authors:  P Nordmann; L Poirel
Journal:  Clin Microbiol Infect       Date:  2002-06       Impact factor: 8.067

2.  Class 1 integron containing metallo-beta-lactamase gene blaVIM-2 in Pseudomonas aeruginosa clinical strains isolated in Japan.

Authors:  Jun Yatsuyanagi; Shioko Saito; Seizaburo Harata; Noriyuki Suzuki; Yuko Ito; Ken-Ichi Amano; Katsuhiko Enomoto
Journal:  Antimicrob Agents Chemother       Date:  2004-02       Impact factor: 5.191

3.  VIM-1 Metallo-beta-lactamase-producing Klebsiella pneumoniae strains in Greek hospitals.

Authors:  P Giakkoupi; A Xanthaki; M Kanelopoulou; A Vlahaki; V Miriagou; S Kontou; E Papafraggas; H Malamou-Lada; L S Tzouvelekis; N J Legakis; A C Vatopoulos
Journal:  J Clin Microbiol       Date:  2003-08       Impact factor: 5.948

4.  Cloning and characterization of blaVIM, a new integron-borne metallo-beta-lactamase gene from a Pseudomonas aeruginosa clinical isolate.

Authors:  L Lauretti; M L Riccio; A Mazzariol; G Cornaglia; G Amicosante; R Fontana; G M Rossolini
Journal:  Antimicrob Agents Chemother       Date:  1999-07       Impact factor: 5.191

5.  Characterization of VIM-2, a carbapenem-hydrolyzing metallo-beta-lactamase and its plasmid- and integron-borne gene from a Pseudomonas aeruginosa clinical isolate in France.

Authors:  L Poirel; T Naas; D Nicolas; L Collet; S Bellais; J D Cavallo; P Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2000-04       Impact factor: 5.191

6.  Multicenter study using standardized protocols and reagents for evaluation of reproducibility of PCR-based fingerprinting of Acinetobacter spp.

Authors:  H J Grundmann; K J Towner; L Dijkshoorn; P Gerner-Smidt; M Maher; H Seifert; M Vaneechoutte
Journal:  J Clin Microbiol       Date:  1997-12       Impact factor: 5.948

7.  Evaluation of a new Etest for detecting metallo-beta-lactamases in routine clinical testing.

Authors:  Timothy R Walsh; Anne Bolmström; Anette Qwärnström; Ana Gales
Journal:  J Clin Microbiol       Date:  2002-08       Impact factor: 5.948

8.  PCR mapping of integrons reveals several novel combinations of resistance genes.

Authors:  C Lévesque; L Piché; C Larose; P H Roy
Journal:  Antimicrob Agents Chemother       Date:  1995-01       Impact factor: 5.191

9.  Metallo-beta-lactamase VIM-2 in clinical isolates of Pseudomonas aeruginosa from Portugal.

Authors:  Olga Cardoso; Rui Leitão; Alexandra Figueiredo; João Carlos Sousa; Aida Duarte; Luísa Vieira Peixe
Journal:  Microb Drug Resist       Date:  2002       Impact factor: 3.431

10.  Carbapenem-resistant Pseudomonas aeruginosa with acquired bla(vim) metallo-beta-lactamase determinants, Italy.

Authors:  G M Rossolini; M L Riccio; G Cornaglia; L Pagani; C Lagatolla; L Selan; R Fontana
Journal:  Emerg Infect Dis       Date:  2000 May-Jun       Impact factor: 6.883
  10 in total
  10 in total

1.  Biogenic Synthesis of ZnO Nanoparticles and Its Potential Use as Antimicrobial Agent Against Multidrug-Resistant Pathogens.

Authors:  Sanaa M F Gad El-Rab; Aly E Abo-Amer; Ahlam M Asiri
Journal:  Curr Microbiol       Date:  2020-04-23       Impact factor: 2.188

2.  Multiniche screening reveals the clinically relevant metallo-beta-lactamase VIM-2 in Pseudomonas aeruginosa far from the hospital setting: an ongoing dispersion process?

Authors:  Sandra Quinteira; Luísa Peixe
Journal:  Appl Environ Microbiol       Date:  2006-05       Impact factor: 4.792

Review 3.  Carbapenemases: the versatile beta-lactamases.

Authors:  Anne Marie Queenan; Karen Bush
Journal:  Clin Microbiol Rev       Date:  2007-07       Impact factor: 26.132

4.  Predominance of KPC-3 in a survey for carbapenemase-producing Enterobacteriaceae in Portugal.

Authors:  Vera Manageiro; Eugénia Ferreira; Joana Almeida; Stephanie Barbosa; Constança Simões; Robert A Bonomo; Manuela Caniça
Journal:  Antimicrob Agents Chemother       Date:  2015-03-16       Impact factor: 5.191

5.  Identification of clinical isolates of indole-positive and indole-negative Klebsiella spp.

Authors:  Maria Silvana Alves; Rubens Clayton da Silva Dias; Angela Christina Dias de Castro; Lee W Riley; Beatriz Meurer Moreira
Journal:  J Clin Microbiol       Date:  2006-08-23       Impact factor: 5.948

Review 6.  Extended-spectrum beta-lactamases: a clinical update.

Authors:  David L Paterson; Robert A Bonomo
Journal:  Clin Microbiol Rev       Date:  2005-10       Impact factor: 26.132

7.  Klebsiella oxytoca Complex: Update on Taxonomy, Antimicrobial Resistance, and Virulence.

Authors:  Jing Yang; Haiyan Long; Ya Hu; Yu Feng; Alan McNally; Zhiyong Zong
Journal:  Clin Microbiol Rev       Date:  2021-12-01       Impact factor: 50.129

8.  Prospective observational study of the impact of VIM-1 metallo-beta-lactamase on the outcome of patients with Klebsiella pneumoniae bloodstream infections.

Authors:  George L Daikos; Panayiotis Petrikkos; Mina Psichogiou; Chris Kosmidis; Evangelos Vryonis; Athanasios Skoutelis; Kleoniki Georgousi; Leonidas S Tzouvelekis; Panayotis T Tassios; Christina Bamia; George Petrikkos
Journal:  Antimicrob Agents Chemother       Date:  2009-02-17       Impact factor: 5.191

9.  Community acquired multi-drug resistant clinical isolates of Escherichia coli in a tertiary care center of Nepal.

Authors:  Shamshul Ansari; Hari Prasad Nepal; Rajendra Gautam; Sony Shrestha; Puja Neopane; Ganga Gurung; Moti Lal Chapagain
Journal:  Antimicrob Resist Infect Control       Date:  2015-05-01       Impact factor: 4.887

10.  Intra- and Extra-Hospital Dissemination of IMP-22-Producing Klebsiella pneumoniae in Northern Portugal: The Breach of the Hospital Frontier Toward the Community.

Authors:  Daniela Gonçalves; Pedro Cecílio; Alberta Faustino; Carmen Iglesias; Fernando Branca; Alexandra Estrada; Helena Ferreira
Journal:  Front Microbiol       Date:  2021-12-14       Impact factor: 5.640
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.